Obesity, oral contraceptives, and fatal pulmonary embolism

New Zealand Medical Journal

Volumn 114, Issue 1129, 2001, Pages 170-171

  Egermayer, Paul ^a  

^a NONE   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

BODY MASS; FEMALE; HEALTH SURVEY; HUMAN; LUNG EMBOLISM; MALE; MORTALITY; NEW ZEALAND; OBESITY; REVIEW; RISK FACTOR; SEX RATIO;

BODY MASS INDEX; CONTRACEPTIVES, ORAL; FEMALE; HUMANS; MALE; NEW ZEALAND; OBESITY; POPULATION SURVEILLANCE; PULMONARY EMBOLISM; RISK FACTORS; SEX DISTRIBUTION;

EID: 0035853737     PISSN: 00288446     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Fleming HA, Bailey SM. Massive pulmonary embolism in healthy people. BMJ 1966; 1: 1322-7.
2. Loehry CA. Pulmonary embolism in young adults. BMJ 1966; 1: 1327-8.
3. Lilienfield DE, Chan E, Ehland J et al. Mortality from pulmonary embolism in the United States 1962-84. Chest 1990; 98: 1067-72.
4. Karwinski B, Svendsen E. Comparison of clinical and postmortem diagnosis of pulmonary embolism. J Clin Pathol 1989; 42: 135-9.
5. Breckenbridge RT, Ratnoff OD. Pulmonary embolism and unexpected death in supposedly normal persons. N Engl J Med 1966; 270: 298-9.
6. Williams S. Body mass index reference curves derived from a New Zealand cohort. NZ Med J 2000; 113: 308-11.
7. Rosendaal FR. Thrombosis in the young: epidemiology and risk factors. A focus on venous thrombosis. Thromb Haemost 1997; 78: 1-6.
8. Bloemenkamp KWM, Rosendaal FR, Hehnerhorst FM et al. Enhancement by Factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen. Lancet 1995; 346: 1593-6.
9. Carter CJ. Epidemiology of venous thromboembolism. In: Hull R, Pineo GF editors. Disorders of thrombosis. Philadelphia: WB Saunders & Co 1996; p159-71.
10. Snell AM. The relation of obesity to fatal postoperative pulmonary embolism. Arch Surg 1927; 15: 237-44.
11. Kakkar VV, Howe CT, Nicolaides AN et al. Deep vein thrombosis of the leg. Is there a high risk group? Am J Surg 1970; 120: 527-30.
12. Coon WW. Epidemiology of venous thromboembolism. Ann Surg 1977; 186: 149-64.
13. Sheridan RL, Rue LW 3rd, McManus WF, Pruitt BA Jr. Burns in morbidly obese patients. J Trauma 1992; 33: 818-20.
14. Kernstein MD, McSwain NE, O'Connel RC et al. Obesity is it really a risk factor in thrombophlebitis? South Med J 1987; 80: 1236-8.
15. Green RM, Meyer TJ, Dunn M et al. Pulmonary embolism in younger adults. Chest 1992; 101: 1507-11.
16. World Health Organisation collaborative study of cardiovascular disease and steroid hormone contraception, venous thromboembolic disease and combined oral contraceptives: results of an international case-control study. Lancet 1995; 346: 1575-82.
17. Goldhaber SZ, Savage DD, Garrson RJ et al. Risk factors for pulmonary embolism in the Framingham study. Am J Med 1983; 74: 1023-8.
18. Goldhaber SZ, Grodstein F, Stampfer MJ et al. A prospective study of risk factors for pulmonary embolism in women. JAMA 1997; 277: 642-5.
19. Farmer RDT, Lawrenson RA, Todd JC et al. A comparison of the risks of venous thromboembolic disease in association with different combined oral contraceptives. Br J Clin Pharmacol 2000; 49: 580-90.
20. Hansson P, Eriksson H, Welin L et al. Smoking and abdominal obesity. Risk factors for venous thromboembolism among middle-aged men: The study of men born in 1913. Arch Intern Med 1999; 159: 1886-90.
21. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346: 1133-4.
22. Heit JA, Siverstein MD, Mohrn DN et al. Predictors of survival after deep vein thrombosis and pulmonary embolism. A population-based, cohort study. Arch Intern Med 1999; 159: 445-53.
23. Heit JA, Silverstein MD, Mohrn DN et al. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 2000; 160: 809-15.
24. Bounameaux H. Factor V Leiden paradox: risk of deep-vein thrombosis but not of pulmonary embolism. Lancet 2000; 356: 182-3.
25. Sundell B, Nilsson T, Randy M et al. Fibrinolytic variables are related to age, sex, blood pressure and body build measurements: a cross sectional study in Norsjo, Sweden. J Clin Epidemiol 1989; 42: 719-23.
26. Landin K, Stigendal L, Eriksson E et al. Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1. Metabolism 1990; 39: 1044-8.
27. Garcia-Monteavaro ML, Rodriguez M, Diez ML, Navarro A. Thromboelasto graphic assays of the clotting process in situations of obesity and caloric restriction. Revista Espanola de Fisiologica 1986; 42: 57-62.
28. Connor WZ. The acceleration of thrombus formation by certain fatty acids. J Clin Invest 1962; 41: 1199-206.
29. Kawasaki T, Kamayashi J, Sakon M. Hyperlipidemia: a novel etiologic factor in deep vein thrombosis.Thromb Res 1995; 79: 147-51.
30. Nielsen HK, Bechgaard P, Nielsen PF et al. 178 fatal cases of pulmonary embolism in a medical department. Acta Med Scand 1981; 209: 351-5.